Cannabinoid CB1 receptor agonists produce cerebellar dysfunction in mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 297, Issue 2, 2001, Pages 629-637

  Patel, Sachin ^a   Hillard, Cecilia J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ANANDAMIDE; APOMORPHINE; BROMOCRIPTINE; CANNABINOID 1 RECEPTOR; CANNABINOID DERIVATIVE; CANNABINOID RECEPTOR AGONIST; DOPAMINE RECEPTOR STIMULATING AGENT; DRONABINOL; DRUG VEHICLE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATAXIA; BASAL GANGLION; BRAIN DYSFUNCTION; CEREBELLUM; CONTROLLED STUDY; DRUG MECHANISM; DRUG RECEPTOR BINDING; GAIT DISORDER; MALE; MOUSE; MUSCLE HYPOTONIA; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BEHAVIOR, ANIMAL; CALCIUM CHANNEL BLOCKERS; CANNABINOIDS; CEREBELLAR DISEASES; CYCLOHEXANOLS; DOPAMINE AGONISTS; GAIT; MALE; MICE; MICE, INBRED ICR; MORPHOLINES; NAPHTHALENES; PIPERIDINES; PYRAZOLES; RECEPTORS, CANNABINOID; RECEPTORS, DRUG;

EID: 0035037811     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. The effects of cannabinoids on the brain
2. 9-tetrahydrocannabinol (THC) on brain activity and cognitive task-induced brain activation: A fMRI study
3. Behavioral effects of cannabinoid agents in animals
4. Purkinje cell expression of a mutant allele of SCA1 in transgenic mice leads to disparate effects on motor behaviors, followed by a progressive cerebellar dysfunction and histological alterations
5. Cannabinoid structure-activity relationships: Correlation of receptor binding and in vivo activities
6. 9-Tetrahydrocannabinol: Dose-related effects on timing behavior in chimpanze
7. 9-THC using a nonionic surfactant
8. 1 receptor in the mouse
9. Effects of glutamate and aspartate on ataxic gait induced by 3-acetyl pyridine in rats
10. Determination and characterization of a cannabinoid receptor in rat brain
11. Cannabinoid pharmacology
12. 2+ channel blockers on apomorphine, bromocriptine and morphine-induced locomotor activity in mice
13. Cannabis-induced catalepsy in mice: Role of putative transmitters
14. The mechanism of cerebellar hypotonia
15. Mouse chimeras in the study of genetic and structural determinants of behavior
16. 9-Tetrahydrocannabinol and the extrapyramidal system
17. Neuronal localization of cannabinoid receptors and second messengers in mutant mouse cerebellum
18. Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1)
19. 8-L-tetrahydrocannabinols in monkeys and mice
20. Measurement of ataxia and related neurological signs in the laboratory rat
21. Aminoalkylindole binding in rat cerebellum: Selective displacement by natural and synthetic cannabinoids
22. Cannabinoids decrease excitatory synaptic transmission and impair long-term depression in rat cerebellar Purkinje cells
23. Effects of SR141716A after acute or chronic cannabinoid administration in dogs
24. Asymmetric tonic labyrinth reflexes and their interaction with neck reflexes in the decerebrate cat
25. The effect of cerebellectomy on tonic labyrinth reflexes in the forelimb of the decerebrate cat
26. Pharmacology and stereoselectivity of structurally novel cannabinoids in mice
27. Cerebellar activity and disturbed time sense after THC
28. Brain stem and cerebellar lesions in female rats. I. Tests of posture and movement
29. The olivocerebellar projection mediates ibogaine-induced degeneration of Purkinje cells: A model of indirect, trans-synaptic excitotoxicity
30. Physiopathology of the cerebellum in the monkey
31. Biochemical and pharmacological selectivity of SR141716A, the first potent and selective brain cannabinoid receptor antagonist
32. Motor actions of cannabinoids in the basal ganglia output nuclei
33. 35S]GTPgS autoradiography in rat brain
34. Cannabinoids. I. Behavioral effects
35. Cannabinoid receptor modulation of synapses received by cerebellar Purkinje cells
36. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
37. Cerebellar metabolic activation by delta-9-tetrahydrocannabinol in human brain: A study with positron emission tomography and 18F-2-fluoro-2-deoxyglucose
38. Structure-activity relationships of indole- and pyrrole-derived cannabinoids
39. The biodisposition and metabolism of anandamide in mice